Ignite Creation Date:
2025-12-24 @ 7:19 PM
Ignite Modification Date:
2026-02-18 @ 12:56 AM
Study NCT ID:
NCT03627403
Status:
TERMINATED
Last Update Posted:
2025-06-19
First Post:
2018-08-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 Inhibitors
Sponsor:
Organization: